Shahd Talhouni
Activated tissue resident memory T-cells (CD8+CD103+CD39+) uniquely predict survival in left sided “immune-hot” colorectal cancers
Talhouni, Shahd; Fadhil, Wakkas; Mongan, Nigel P.; Field, Lara; Hunter, Kelly; Makhsous, Sogand; Maciel-Guerra, Alexandre; Kaur, Nayandeep; Nestarenkaite, Ausrine; Laurinavicius, Arvydas; Willcox, Benjamin E.; Dottorini, Tania; Spendlove, Ian; Jackson, Andrew M.; Ilyas, Mohammad; Ramage, Judith M.
Authors
Wakkas Fadhil
Professor Nigel Mongan nigel.mongan@nottingham.ac.uk
ASSOCIATE PRO-VICE CHANCELLORGLOBAL ENGAGEMENT
Lara Field
Kelly Hunter
Sogand Makhsous
Alexandre Maciel-Guerra
Nayandeep Kaur
Ausrine Nestarenkaite
Arvydas Laurinavicius
Benjamin E. Willcox
Professor TANIA DOTTORINI TANIA.DOTTORINI@NOTTINGHAM.AC.UK
PROFESSOR OF BIOINFORMATICS
Dr IAN SPENDLOVE IAN.SPENDLOVE@NOTTINGHAM.AC.UK
ASSOCIATE PROFESSOR
Dr ANDREW JACKSON ANDREW.JACKSON@NOTTINGHAM.AC.UK
ASSOCIATE PROFESSOR
Professor MOHAMMAD ILYAS mohammad.ilyas@nottingham.ac.uk
PROFESSOR OF PATHOLOGY
Dr Judith Ramage JUDITH.RAMAGE@NOTTINGHAM.AC.UK
ASSOCIATE PROFESSOR
Abstract
Introduction: Characterization of the tumour immune infiltrate (notably CD8+ T-cells) has strong predictive survival value for cancer patients. Quantification of CD8 T-cells alone cannot determine antigenic experience, as not all infiltrating T-cells recognize tumour antigens. Activated tumour-specific tissue resident memory CD8 T-cells (TRM) can be defined by the co-express of CD103, CD39 and CD8. We investigated the hypothesis that the abundance and localization of TRM provides a higher-resolution route to patient stratification. Methods: A comprehensive series of 1000 colorectal cancer (CRC) were arrayed on a tissue microarray, with representative cores from three tumour locations and the adjacent normal mucosa. Using multiplex immunohistochemistry we quantified and determined the localization of TRM. Results: Across all patients, activated TRM were an independent predictor of survival, and superior to CD8 alone. Patients with the best survival had immune-hot tumours heavily infiltrated throughout with activated TRM. Interestingly, differences between right- and left-sided tumours were apparent. In left-sided CRC, only the presence of activated TRM (and not CD8 alone) was prognostically significant. Patients with low numbers of activated TRM cells had a poor prognosis even with high CD8 T-cell infiltration. In contrast, in right-sided CRC, high CD8 T-cell infiltration with low numbers of activated TRM was a good prognosis. Conclusion: The presence of high intra-tumoural CD8 T-cells alone is not a predictor of survival in left-sided CRC and potentially risks under treatment of patients. Measuring both high tumour-associated TRM and total CD8 T-cells in left-sided disease has the potential to minimize current under-treatment of patients. The challenge will be to design immunotherapies, for left-sided CRC patients with high CD8 T-cells and low activate TRM,that result in effective immune responses and thereby improve patient survival.
Citation
Talhouni, S., Fadhil, W., Mongan, N. P., Field, L., Hunter, K., Makhsous, S., Maciel-Guerra, A., Kaur, N., Nestarenkaite, A., Laurinavicius, A., Willcox, B. E., Dottorini, T., Spendlove, I., Jackson, A. M., Ilyas, M., & Ramage, J. M. (2023). Activated tissue resident memory T-cells (CD8+CD103+CD39+) uniquely predict survival in left sided “immune-hot” colorectal cancers. Frontiers in Immunology, 14, Article 1057292. https://doi.org/10.3389/fimmu.2023.1057292
Journal Article Type | Article |
---|---|
Acceptance Date | Apr 21, 2023 |
Online Publication Date | May 11, 2023 |
Publication Date | Jan 1, 2023 |
Deposit Date | May 17, 2023 |
Publicly Available Date | May 18, 2023 |
Journal | Frontiers in Immunology |
Electronic ISSN | 1664-3224 |
Publisher | Frontiers Media |
Peer Reviewed | Peer Reviewed |
Volume | 14 |
Article Number | 1057292 |
DOI | https://doi.org/10.3389/fimmu.2023.1057292 |
Keywords | cancer, multiplex IHC/IF, T-cells, colorectal cancer, immune microenvironment, tissue resident T cells, CD8 T-cells |
Public URL | https://nottingham-repository.worktribe.com/output/20835062 |
Publisher URL | https://www.frontiersin.org/articles/10.3389/fimmu.2023.1057292/full?&utm_source=Email_to_authors_&utm_medium=Email&utm_content=T1_11.5e1_author&utm_campaign=Email_publication&field=&journalName=Frontiers_in_Immunology&id=1057292 |
Additional Information | School of Medicine University of Nottingham Biodiscovery Institute |
Files
fimmu-14-1057292
(9.1 Mb)
PDF
Publisher Licence URL
https://creativecommons.org/licenses/by/4.0/
You might also like
EPEN-08. THE TREM1 POSITIVE HYPOXIC MYELOID SUBPOPULATION IN POSTERIOR FOSSA EPENDYMOMA
(2021)
Journal Article
Epen-23. A computational analysis of the tumour immune microenvironment in paediatric ependymoma
(2020)
Presentation / Conference Contribution
Downloadable Citations
About Repository@Nottingham
Administrator e-mail: discovery-access-systems@nottingham.ac.uk
This application uses the following open-source libraries:
SheetJS Community Edition
Apache License Version 2.0 (http://www.apache.org/licenses/)
PDF.js
Apache License Version 2.0 (http://www.apache.org/licenses/)
Font Awesome
SIL OFL 1.1 (http://scripts.sil.org/OFL)
MIT License (http://opensource.org/licenses/mit-license.html)
CC BY 3.0 ( http://creativecommons.org/licenses/by/3.0/)
Powered by Worktribe © 2025
Advanced Search